References
- Poiesz B J., Rusceti F W., Gazdar A F., Bunn P A., Minna J D., Gallo R C. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980; 77: 7415–9
- Kalyanaraman V S., Sarngadharan M G., Robert-Guroff M, Miyoshi I, Blayney D, Golde D, Gallo R C. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982; 218: 571–3
- Barre-Sinoussi F, Chermann J C., Rey F, et al. Isolation of a T-lymphotrophic retrovirus from a patient a risk of acquired immune deficiency syndrome (AIDS). Science 1983; 220: 868–70
- Popovic M, Sarngadharan M G., Read E, Gallo R C. Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-II) from patients with AIDS and Pre-AIDS. Science 1984; 2224: 497–500
- Clavel F, Guyader M, Guetard D, Salle M, Montagnier L, Alizon M. Molecular cloning and polymorphism of the human immunodeficiency virus type 2. Nature 1986; 324: 691–5
- Hinuma Y, Nagata K, Hanaoka M, et al. Adult T-cell leukemia: antigen in an ATL cell line and detection of antibodies to the antigen in human sera. Proc Natl Acad Sci USA 1981; 78: 6476–80
- Osame M, Usuku K, Izumo S, et al. HTLV-I associated myelopathy, a new clinical entity. Lancet 1986; 1: 1031–2
- Gessaim A, Barin F, Vernant J C., et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985; ii: 407–10
- Saxinger W, Blattner W A., Levine P H., et al. Human T-cell leukemia (HTLV-I) antibodies in Africa. Science 1984; 225: 1473–6
- Rosenblatt J D., Golde D W., Wachsman W, et al. A second isolate of HTLV-II associated with a typical hairy-cell leukemia. N Engl J Med 1986; 313: 372–7
- Lee H, Swanson P, Shorty V S., Zack J A., Rosenblatt J D., Chen I SY. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989; 244: 471–5
- Kwok S, Gallo D, Hanson C, McKinney N, Poiesz B, Sninsky J J. High prevalence of HTLV-II among intravenous drug abusers: PCR confirmation and typing. AIDS Res Hum Retroviruses 1990; 6: 559–63
- Zella D, Mori L, Sala M, et al. HTLV-II infection in Italian drug abusers. Lancet 1990; ii: 572–6
- Lairmore M D., Jacobson S, Gracia F, et al. Isolation of human T-cell lymphotropic virus type 2 from Guaymi Indians in Panama. Proc Natl Acad Sci USA 1990; 87: 8840–4
- Delaporte E, Louwagie J, Peeters M, et al. Evidence for HTLV-II infection in Central Africa. AIDS 1991; 5: 771–2
- Wittek A E., Phelan M A., Well M A., et al. Detection of human immunodeficiency virus core protein in plasma by enzyme immunoassay. Ann Intern Med 1987; 107: 286–92
- Kwok S, Mack D H., Mullis K B., et al. Identification of human immunodeficiency virus sequences by using in vitro enzymatic amplification and oligomer cleavage detection. J Virol 1987; 61: 1690–4
- Kwok S, Ehrlich G, Van den Kalish R, Sninsky J J. Enzymatic amplification of HTLV-I viral sequences from peripheral blood mononuclear cells and infected tissues. Blood 1988; 72: 1117–23
- Rogers M F., Ou C Y., Rayfield M, et al. Use of the polymerase chain reaction for early detection of the proviral sequences of human immunodeficiency virus in infants born to seropositive mothers. J Engl J Med 1989; 320: 1649–54
- Chadwick E G., Yogev R, Kwok S, Sninsky J J., Kellogg D E., Wolinsky S M. Enzymatic amplification of the human immunodeficiency virus in peripheral blood mononuclear cells from pediatric patients. J infect Dis 1989; 160: 954–9
- De Rossi A, Ades A E., Mammano F, et al. Antigen detection, virus culture, polymerase chain reaction, and in vitro antibody production in the diagnosis of vertically transmitted HIV-1 infection. AIDS 1991; 5: 15–20
- Centers for Disease Control. Interpretation and use of the Western blot assay for serodiagnosis of human immunodeficiency virus type 1 infections. MMWR 1989; 38(S-7)1–7
- Jackson J B., MacDonald K L., Cadwell J, et al. Absence of HIV infection in blood donors with indeterminate Western blot tests for antibody to HIV-1. N Engl J Med 1990; 322: 217–22
- Celum C, Coombs R, Lafferty W, et al. Indeterminate HIV-1 Western blots: seroconversion risk, specificity of supplemental tests, and an algorithm for evaluation. J Infect Dis 1991; 164: 656–64
- Lipka J J., Young K KY, Kwok S Y., Reyes G R., Sninsky J J., Foung S KH. Significance of human T-lymphotropic virus type I indeterminant serological findings among healthy individuals. Vox Sang 1991; 61: 171–6
- Imagawa D T., Lee M H., Wolinsky S M., et al. Long latency of human immunodeficiency virus-1 in seronegative high risk homosexual men determined by prospective virus isolation and DNA amplification studies. N Engl J Med 1989; 320: 1458–62
- Loche M, Mach B. Identification of HIV-infected seronegative individuals by a direct diagnostic test based on hybridisation to amplified viral DNA. Lancer 1988; ii: 418–21
- Jackson J B., Kwok S Y., Höpsicker J S., et al. Absence of HIV-1 infection in antibody-negative sexual partners of HIV-1 infected hemophiliacs. Transfusion 1989; 29: 265–7
- Sheppard H W., Dondero D, Arnon J, Winkelstein W. An evaluation of the polymerase chain reaction in HIV-1 seronegative men. JAIDS 1991; 4: 819–23
- Wormser G P., Joline C, Van den Forseter G, Kwok S Y., Sninsky J J. Polymerase chain reaction for seronegative health care workers with parenteral exposure to HIV-infected patients. N Engl J Med 1989; 321: 1681
- Tedder R S., Van den Corrah T, Whittle H. Envelope cross reactivity in Western blot for HIV-1 and HIV-2 may not indicate dual infection. Lancet 1988; ii: 927–30
- Kanki P J., Van den Ricard D, et al. Human T-lymphotropic retrovirus type 4 and the human immunodeficiency virus in West Africa. Science 1987; 236: 827–31
- Rayfield M, Oecock K, Heyward W, et al. Mixed human immunodeficiency virus (HIV) infection in an individual: Demonstration of both HIV type 1 and type 2 proviral sequences by using polymerase chain reaction. J Infect Dis 1988; 158: 1170–6
- Simon F, Cot M C., Lesager C, et al. Differentiation between HIV-1 and HIV-2 infection by radioimmunoprecipitation and synthetic peptides in double reactive sera. AIDS 1989; 3: 401–4
- Viscidi R P., Hill P M., Li S, et al. Diagnosis and differentiation of HTLV-I and HTLV-II infection by enzyme immunoassays using synthetic peptides. JAIDS 1991; 4: 1190–8
- Starcich B, Hahn B, Shaw G, McNeely P, et al. Identification and characterization of conserved and variable regions in the envelope gene of HTLV-III/LAV, the retrovirus of AIDS. Cell 1986; 45: 637–48
- Goodenow M, Huet T, Saurin W, Kwok S, Sninsky J, Wain-Hobson S. HIV-1 isolates are rapidly evolving quasispecies: evidence for viral mixtures and preferred nucleotide substitutions. JAIDS 1989; 2: 344–352
- Meyerhans A, Cheynier R, Albert J, et al. Temporal fluctuations in HIV quasispecies in vivo are not reflected by sequential HIV isolations. Cell 1989; 58: 901–910
- Update: Transmission of a HIV infection during invasive dental procedures-Florida. MMWR 1991; 40: 377–81
- McClutchan F E., Sanders-Buell E, Oster C W., et al. Genetic comparison of human immunodeficiency virus (HIV-1) isolates by polymerase chain reaction. JAIDS 1991; 4: 1241–50
- Larder B A., Kemp S D. Multiple mutations in HIV-1 reverse transcriptase confer high-level resistance to zidovudine (AZT). Science 1989; 246: 1155
- Larder B A., Kellam P, Kemp S D. Zidovudine resistance predicted by direct detection of mutations in DNA from HIV-infected lymphocytes. AIDS 1991; 5: 137–44
- St Clair M H., Martin J L., Tudor-Williams G, et al. Resistance to ddl and sensitivity to AZT induced by a mutation in HIV-1 reverse transcriptase. Science 1991; 253: 1557–9
- Nunberg J H., Schleif W A., Boots E J., et al. Viral resistance to human immunodeficiency virus type 1-specific pyridinone reverse transcriptase inhibitors. J Virol 1991; 65: 4887–92
- Pang S, Koyanagi Y, Miles S, Wiley C, Vinters H V., Chen I SY. High levels of unintegrated HIV DNA in brain tissue of AIDS demential patients. Nature 1990; 343: 85–9
- Dickover R E., Donovan R M., Goldstein E, et al. Decreases in unintegrated HIV DNA are associated with antiretroviral therapy in AIDS patients. JAIDS 1992; 5: 31–6
- Clark A GB, Holodniy M, Schwartz D H., Katzenstein D A., Merigan T C. Decrease in HIV provirus in peripheral blood mononuclear cells during zidovudine and human rlL-2 administration. JAIDS 1992; 4: 52–59
- Bagnarelli P, Menzo S, Manzin A, Giacca M, Varaldo P E., Clementi M. Detection of human immunodeficiency virus type 1 genomic RNA in plasma samples by reverse-transcription polymerase chain reaction. J Med Virol 1991; 34: 89–95
- Michael N L., Vahey M, Bruke D S., Redfield R R. Viral DNA and mRNA expression correlate with the stage of human immunodeficiency virus (HIV) Type 1 infection in humans: Evidence for viral replication in all stages of HIV disease. J Virol 1992; 66: 310–6
- Kwok S, Kellogg D E., McKinney N, Spasic D, Goda L, Levenson C, Sninsky J J. Effects of primer-template mismatches on the polymerase chain reaction: Human immunodeficiency virus type 1 model studies. Nucleic Acids Res 1990; 18: 999–1005
- Cassol S, Salas T, Lapointe N, Arella M, Rudnik J, O'Shaughnessy M. Improved detection of HIV-1 envelope sequences using optimized PCR and inosine-substituted primers. Mol Cell Probes 1991; 5: 157–60
- Faloona F, Weiss S, Ferre F, Mullis K. Direct detection of HIV sequences in blood: high gain polymerase chain reaction. Abstract 1019, 6th Intl Conf AIDS. San Francisco, CA 1990
- Nuovo G, Gallery F, MacConnell P, Becker J, Bloch W. An improved technique for the in situ detection of DNA after polymerase chain reaction implification. Am J Pathol 1991; 139: 1239–44
- Myers T, Gelfand D H. Reverse transcription and DNA amplification by a Thermus thermophilus DNA polymerase. Biochemistry 1991; 30: 7661–6
- Wong K K., McClellan A. PCR with 5-methyl-dCTP replacing dCTP. Nucleic Acids Res 1991; 19: 1081–5
- Isaacs S T., Tessman J W., Metchette K C., Hearst J E., Cimino G. Post-PCR sterilization: development and application to an HIV-1 diagnostic assay. Nucleic Acids Res 1991; 19: 109–16
- Longo M C., Berninger M S., Hartley J L. Use of uracil DNA glycosylase to control carryover contamination in polymerase chain reactions. Gene 1990; 93: 125–8
- Kellogg D E., Gates C, Dragon B, Kung K, Wang J, Kwok S, Sninsky J J. Uracil-N-glycosylase (UNG) elimination of HIV PCR carryover. Abstract Th.A. 16, 7th Conf AIDS. 1991
- Schochetman G, Sninsky J J. Direct detection of human immunodeficiency virus infection using the polymerase chain reaction. AIDS Testing Methodology and Management., G Schochetman, J George, Richard. Springer-Verlag, New York 1992; 90: 110
- Jackson J B., Ndugwa C, Mmiro F, et al. Non-isotopic polymerase chain reaction methods for the detection of HIV-1 in Ugandan mothers and infants. AIDS 1991; 5: 1463–7